AVH - AVITA Medical, Inc

[finicky]

0AVH smashed, down 20% upon FDA letter to the Company that is requesting additional information on its latest device, RECELL GO.
Another uninvestable biotech, just a chart follow and maybe a punt here or there for a trader so inclined.

Not Held

 

[UMike]

Almost May 24 Still AVH:ASX ---- $4.830

Many Brokers still love this stock though........
?????

 

[rcw1]

Good morning

Q3 2024 FINANCIAL RESULTS
Commercial revenue: • $19.5 million, an increase of ~44% year-over-year Gross profit margin:
• 83.7%
Cash and cash equivalents:
• As of September 30, 2024: approximately $44.4 million
• Sufficient capital to meet goals and reach profitability

2024 FINANCIAL GUIDANCE
Commercial revenue:
• Q4 2024: expect $22.3 to $24.3 million, representing ~58% to 72% growth year-over-year
• FY 2024: expect $68 to $70 million, reflecting a growth rate of over 37% to 41% year-over-year and our ongoing growth trajectory
• Reaffirming our expectation to achieve cashflow break even and GAAP profitability by the end of Q3 2025

 

[Avid]

AVH My tip in the tipping comp. After the recent announcement the share price has been smashed. They stated the will be cash flow positive by Q4 2025. Huge overreaction. Much upside this year.

 

[Avid]

AVH My tip in the tipping comp. After the recent announcement the share price has been smashed. They stated the will be cash flow positive by Q4 2025. Huge overreaction. Much upside this year.

 

[Avid]

Looks like another good day today.

 

[Dona Ferentes]

After the recent announcement the share price has been smashed. They stated the will be cash flow positive by Q4 2025. Huge overreaction. ...

there's always resets of information

From 08 Jan ...For the quarter ended December 31, 2024, AVITA Medical now expects commercial revenue to be approximately $18.4 million, reflecting growth of around 30% over the same period in 2023. Previously provided fourth-quarter guidance was in the range of $22.3 million to $24.3 million.

Based on these quarterly results, the company expects full-year 2024 commercial revenue to be approximately $64.3 million, reflecting growth of about 29% over the full year 2023. Previously provided full-year 2024 revenue guidance was in the range of $68.0 million to $70.0 million.

The revision in fourth-quarter guidance is attributable to ...etc.

that's a downgrade. "Spreadsheet say sell"